Live Breaking News & Updates on Acheson Group|Page 5

Stay updated with breaking news from Acheson group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors


Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors
Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors
HAUPPAUGE, N.Y., Dec. 17, 2020 Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of David Acheson, M.D. to the Company’s Board of Directors.
“We are pleased to welcome David to our Board of Directors. He adds directly applicable expertise in public health and infectious disease management to our leadership team, and we are confident his perspective will contribute meaningfully to our long-term value creation strategy,” said Katherine L. Davis, Chair of Chembio’s Board of Directors. “We look forward to his leadership and insights as we enter the next phase of growth for Chembio.” ....

United States , United Kingdom , City Of , David Acheson , Katherinel Davis , University Of London Medical School , England Medical Center , Royal College Of Physicians London , Philip Taylor Gilmartin Group , Company Board Of Directors , Infectious Disease Society Of America , World Health Organization , Drug Administration , Professor For Tufts University , Acheson Group , Chembio Diagnostics Inc , Chembio Diagnostics , Chief Executive Officer , Managing Director , Leavitt Partners , Chief Medical Officer , Food Safety , Applied Nutrition , Associate Commissioner , New England Medical Center , Associate Professor ,

PathogenDx Appoints Dr. David Acheson as a Strategic Advisor to Chair Its New Food Safety Committee


Share:
SCOTTSDALE, Ariz., Dec. 14, 2020 /PRNewswire/  PathogenDx, Inc., an Arizona based technology company which has developed a multiplexed microarray DNA-based pathogen testing platform, announced today that Dr. David Acheson will join the company as a strategic advisor. As part of the role, Dr. Acheson will form a food safety committee that will inform the company s development of rapid detection testing technologies for the food industry.
Dr. Acheson brings more than 35 years of medical and food safety research and experience to PathogenDx. Formally trained in internal medicine and infectious diseases, he left his practice to teach and study at Tufts University in Boston, where he researched the molecular pathogenesis of foodborne pathogens. Subsequently, he was tapped to serve as Chief Medical Officer at both the USDA Food Safety and Inspection Service as well as the U.S. Food and Drug Administration at the Center for Food Safety and Applied Nutrition (CFSAN), and ....

Tufts University , United States , David Acheson , Pathogendx Inc , Us Department Of Agriculture , Acheson Group , Inspection Service , Drug Administration , Agricultural Research Service , Chief Medical Officer , Food Safety , Applied Nutrition , Associate Commissioner , Milan Patel , டஃப்ட்ஸ் பல்கலைக்கழகம் , ஒன்றுபட்டது மாநிலங்களில் , டேவிட் அச்செஸ்ன் , அச்செஸ்ன் குழு , ஆய்வு சேவை , தலைமை மருத்துவ அதிகாரி , உணவு பாதுகாப்பு , பயன்படுத்தப்பட்டது ஊட்டச்சத்து , இணை ஆணையர் , மிலன் படேல் ,